9 Systemic Lupus Erythematosus Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Systemic Lupus Erythematosus Studies in Phoenix

NCT00830557Recruiting

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic c...

Phoenix, AZ20,000 participantsMayo Clinic

View Study Details

NCT07691970Recruiting

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

The purpose of this study is to provide continued access to anifrolumab to eligible participants who are continuing to derive clinical benefit from treatment at the end of a parent clinical study, as ...

Phoenix, AZPHASE31,072 participantsAstraZeneca

View Study Details

NCT06617325Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of mo...

Phoenix, AZPHASE3450 participantsUCB Biopharma SRL

View Study Details

NCT07765849Recruiting

Online Sleep Education for College Student's Sleep Health and Executive Functioning

The goal of this clinical trial is to determine if asynchronous psychoeducational sleep intervention works to improve college students' levels of self-reported sleep health literacy, sleep quality, an...

Phoenix, AZNA300 participantsNorthern Arizona University

View Study Details

NCT07430306Recruiting

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti...

Phoenix, AZPHASE3245 participantsAstraZeneca

View Study Details

NCT05268289Recruiting

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment....

Phoenix, AZPHASE2240 participantsNovartis Pharmaceuticals

View Study Details

NCT05835310Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE...

Phoenix, AZPHASE3100 participantsAstraZeneca

View Study Details

NCT07085104Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

This is a first-in-human, single-arm, open-label study evaluating the safety, tolerability, and preliminary efficacy of ALLO-329 in adults with autoimmune diseases: systemic lupus erythematosus (SLE) ...

Phoenix, AZPHASE166 participantsAllogene Therapeutics

View Study Details

NCT06851338Recruiting

Pediatric Down Syndrome Post-Approval Study

The purpose of this Post Approval research study is to assess ongoing safety and effectiveness of the Inspire therapy in adolescents and young adults (age 13-18) with Down syndrome and severe sleep ap...

Phoenix, AZNA60 participantsInspire Medical Systems, Inc.

View Study Details

About Systemic Lupus Erythematosus Clinical Trials in Phoenix

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, blood cells, brain, heart, and lungs. It is characterized by periods of flares and remission. Treatment includes antimalarials, immunosuppressants, corticosteroids, and biologics like belimumab.

There are currently 9 systemic lupus erythematosus clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 22,533 participants. Research is being sponsored by Mayo Clinic, AstraZeneca, UCB Biopharma SRL and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Systemic Lupus Erythematosus Clinical Trials in Phoenix — FAQ

Are there systemic lupus erythematosus clinical trials in Phoenix?

Yes, there are 9 systemic lupus erythematosus clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What systemic lupus erythematosus treatments are being tested?

The 9 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for systemic lupus erythematosus.

Data updated October 15, 2026 from ClinicalTrials.gov